Deep vein thrombosis (DVT) treatment
DVT requires prompt medical assessment because a clot can travel to the lungs and cause pulmonary embolism (PE).
Go to emergency care now for chest pain, shortness of breath, coughing blood, fainting, a very fast heartbeat, or severe worsening leg swelling or pain.
Main treatment: anticoagulation
Anticoagulants prevent clot enlargement and new clots while the body gradually breaks down the existing clot. They are not “clot-busters.”
For most adults with confirmed proximal leg DVT and no contraindication, treatment is an anticoagulant, often:
- A direct oral anticoagulant (DOAC), such as apixaban or rivaroxaban
- Low-molecular-weight heparin or unfractionated heparin, followed by an oral anticoagulant in some situations
- Warfarin when DOACs are unsuitable, including certain patients with antiphospholipid syndrome, severe renal impairment, or cost/access limitations
DOACs are commonly preferred for many non-cancer DVT cases because they usually do not require routine INR monitoring. Treatment choice must account for kidney function, pregnancy, active cancer, bleeding risk, interacting medicines, and whether the clot is in a proximal or calf vein. Harrison's Principles of Internal Medicine, p. 2205.
How long is treatment?
- DVT provoked by a temporary risk factor such as surgery, trauma, immobilization, or estrogen therapy: usually at least 3 months.
- Unprovoked DVT, recurrent DVT, or DVT associated with a lasting risk factor: treatment beyond 3 to 6 months, sometimes indefinitely, may be appropriate if bleeding risk is acceptable.
- Duration should be reviewed individually. The ASH guideline summary describes initial management, primary treatment for 3 to 6 months, and extended secondary prevention when indicated.
When treatment differs
- Isolated calf DVT: some patients need anticoagulation; selected low-risk cases may instead have repeat ultrasound surveillance. The decision depends on symptoms and risk of extension.
- Pregnancy: low-molecular-weight heparin is generally used. DOACs and warfarin are generally avoided during pregnancy.
- Cancer-associated DVT: a DOAC or low-molecular-weight heparin may be used, chosen around bleeding risk, especially with gastrointestinal or genitourinary cancers.
- Catheter-associated upper-extremity DVT: anticoagulation is generally used, commonly for at least 3 months, while management of the catheter is individualized.
Clot-dissolving or procedural treatment
Thrombolysis, catheter-directed therapy, or thrombectomy are not routine. They may be considered for selected people with extensive acute iliofemoral DVT, severe symptoms, threatened limb circulation, and low bleeding risk. Evidence has not shown an overall reduction in post-thrombotic syndrome with routine catheter-directed thrombolysis. Harrison's Principles of Internal Medicine, p. 2205.
IVC filters
An inferior vena cava (IVC) filter is generally reserved for a proximal DVT when anticoagulation is impossible because of a major bleeding contraindication. It is not a usual substitute for anticoagulant treatment and can itself increase later thrombosis risk.
Supportive measures
- Walk and mobilize as tolerated once anticoagulation has begun, unless a clinician advises otherwise.
- Elevate the affected leg for comfort.
- Compression stockings can help acute swelling or discomfort in some people, but routine use does not reliably prevent post-thrombotic syndrome. Harrison's Principles of Internal Medicine, p. 2205.
- Avoid stopping an anticoagulant, taking NSAIDs such as ibuprofen/naproxen, or adding aspirin/herbal supplements without clinician or pharmacist advice because bleeding risk can rise.
Important anticoagulant safety signs
Seek urgent care for black stools, vomiting blood, severe headache, unexplained large bruises, prolonged bleeding, heavy vaginal bleeding, a fall/head injury, or new neurological symptoms while taking an anticoagulant.
This is general information, not a personal treatment plan. A suspected DVT should be confirmed promptly, usually with compression ultrasound, before treatment decisions are made.